ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1943

Prevalence and Evolution of Undifferentiated Periodic Fever Syndromes in an Academic Pediatric Rheumatology Practice

Jacob Anderson1, Catherine Bingham2, Lisabeth Scalzi3, Natalya Gaffney4, Kimberly Hays5, Brandt Groh2 and Timothy Hahn2, 1Phoenix Children's Hospital, Phoenix, AZ, 2Penn State Children's Hospital, Hershey, PA, 3Penn State Health, Hummelstown, PA, 4Self-Employed, Carlisle, PA, 5Penn State Health, Hershey, PA

Meeting: ACR Convergence 2022

Keywords: Autoinflammatory diseases, Juvenile idiopathic arthritis, Pediatric rheumatology, Periodic Disease

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Title: Pediatric Rheumatology – Clinical Poster III: Other

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Periodic Fever Syndromes (PFS) are common referrals to pediatric rheumatology clinics. While the syndrome of Periodic Fevers, Aphthous stomatitis, Pharyngitis, and Adenitis (PFAPA) is the most common PFS diagnosis in primary care clinics, patients with monogenic autoinflammatory diseases (AID) and undifferentiated PFS presentations (genotype negative) are enriched in subspecialty clinic settings. The availability of Periodic Fever Syndrome panels that screen for the most common AID gene mutations has progressively increased the number of genetic diagnoses in pediatric rheumatology over the past 2 decades. We present herein a summary of our clinic experience with a specific focus on undifferentiated PFS patients.

Methods: All PFS patients who were evaluated in our Pediatric Rheumatology clinics at least twice between July of 2005 and July of 2019 are included in this review. Genotyping prior to 2005 followed a candidate gene approach, whereas genotyping after that year included a broader panel of AID mutations in 7-12 genes (GeneDx and Invitae Labs, respectively).

Results: 147 unique patients with periodic fever syndromes were evaluated over the course of this 14-year interval. Of these, 49 (33.1%) were classified as PFAPA without need for genotyping. 73 (49.7%) were genotyped, with 26 (35.6%) having an identified monogenic AID, while 47 (64.4%) had negative results and were assigned a diagnosis of undifferentiated PFS (UDPFS). In comparing the UDPFS patients to the PFAPA group, we found that the UDPFS group contained a higher percentage of females (62% versus 48%) and was more ethnically diverse. There was no statistical difference in age of onset, fever periodicity, duration of episodes, or time to remission. We identified a number of sibling pairs in our PFS population, and 6 pairs comprised one sib with PFS and the other with JIA; 5 out of these 6 PFS sibs were classified as UDPFS. While fevers in these UDPFS sibs remitted, all progressed to a JIA phenotype consistent with early enthesitis-related arthritis or psoriatic arthritis.

Conclusion: Within our clinic population of PFS, approximately 2/3 who were genotyped remain undifferentiated based on negative mutation screening. Of interest, some of these UDPFS patients have evolved to a JIA phenotype identical to that of their sibling. Further genotyping of these JIA sib pairs may reveal polymorphisms common to both PFS and JIA.

Supporting image 1

Sib Pairs with overlapping PFS/JIA


Disclosures: J. Anderson, None; C. Bingham, None; L. Scalzi, None; N. Gaffney, None; K. Hays, None; B. Groh, None; T. Hahn, None.

To cite this abstract in AMA style:

Anderson J, Bingham C, Scalzi L, Gaffney N, Hays K, Groh B, Hahn T. Prevalence and Evolution of Undifferentiated Periodic Fever Syndromes in an Academic Pediatric Rheumatology Practice [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/prevalence-and-evolution-of-undifferentiated-periodic-fever-syndromes-in-an-academic-pediatric-rheumatology-practice/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-and-evolution-of-undifferentiated-periodic-fever-syndromes-in-an-academic-pediatric-rheumatology-practice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology